Results 121 to 130 of about 10,952 (242)

Attitudes of European psychiatrists on psychedelics: a qualitative study

Frontiers in Psychiatry
Introduction and aimIt is important to understand how mental health practitioners view recent findings on psychedelic-assisted psychotherapy (PAP) as there is potential this treatment may be incorporated into clinical practice.
Marija Franka Žuljević, Nando Breški, Mariano Kaliterna, Darko Hren   +3 more
doaj   +1 more source

Long‐Term Therapy Experiences in Post‐suicidal Men: Safety, Gender and Iatrogenic Harm

MultiPsych, Volume 1, Issue 3, September 2026.
Men who have survived a suicide attempt and engaged in long‐term psychotherapy describe the therapeutic relationship as the primary agent of recovery—not technique, but sustained relational presence. Gender dynamics, developmental history and institutional failure all shape engagement. These findings challenge short‐term service models and carry direct
Alastair Coomes, Joel Vos, Ron Roberts
wiley   +1 more source

Contribution of the Serotonin 5‐HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress

Neuropsychopharmacology Reports, Volume 46, Issue 3, September 2026.
Psilocin, the active metabolite of psilocybin, ameliorated social avoidance behavior in mice exposed to chronic social defeat stress when administered after, but not before, stress exposure via serotonin 5‐HT2A receptor activation. These findings suggest that psilocin exerts therapeutic, but not preventive, effects on stress‐induced social behavioral ...
Daisuke Ibi, Rika Takaba, Keisuke Yoshida, Ririna Kawase, Hiroko Kitagawa, Momoko Matsushita, Kana Ito, Shoya Uno, Fumiya Nishimura, Shinji Kitagaki, Masayuki Hiramatsu   +10 more
wiley   +1 more source

Psychiatric effects of cannabidiol, cannabinol, and tetrahydrocannabinol: A narrative review of clinical evidence and risk profiles

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.
Abstract Cannabinoid products are increasingly used worldwide despite limited psychiatric evidence. This narrative review synthesizes preclinical and clinical evidence on cannabidiol (CBD), cannabinol (CBN), and tetrahydrocannabinol (THC) to clarify their distinct psychiatric profiles and discuss how current evidence may inform ongoing clinical and ...
Yasuhiro Kishi, Ichiro Takumi, Kakusho Chigusa Nakajima‐Ohyama   +2 more
wiley   +1 more source

Critical appraisal of evidence supporting prescription of psychedelics from clinic websites in Ontario, Canada.

PLoS ONE
Psychedelics, including ketamine, 3,4-Methyl enedioxy methamphetamine (MDMA), and psilocybin, have gained attention for their potential therapeutic role in mental health treatment.
Kyurim Kim, Abban Yusuf, Abhimanyu Sud, Nav Persaud, Abirami Kirubarajan, Monique Moller, Taryn Lloyd, Braden O'Neill   +7 more
doaj   +1 more source

The therapeutic potentials of psychedelics

, 2017
In this dissertation; the history of the use of psychedelic substances, the studies concerning these substances, the methodologies and results of these studies, the future of the potential use of psychedelic substances, and the obstacles that scientists ...
Hajighanbari, Farnoosh
core  

Societal perspectives on psychedelics use in clinical context: Development of Concerns and Openness towards Psychedelic Scale (COPS)

Dialogues in Clinical Neuroscience
Introduction Psychedelics are gaining recognition for their therapeutic potential in mental health treatment, yet societal attitudes remain divided, influenced by both skepticism and curiosity.
Paweł Holas, Justyna Kamińska, Marcin Zajenkowski   +2 more
doaj   +1 more source

Drug sellers' use of a drug checking service amid the overdose crisis in British Columbia, Canada

Addiction, Volume 121, Issue 9, Page 2470-2481, September 2026.
Abstract Aims This study examined the use of a drug checking service by drug sellers in British Columbia, Canada, to assess motivations for service use and substances intended for distribution, focusing on risks associated with an unstable illicit drug market.
Pablo Gonzalez‐Nieto, Bruce Wallace, Collin Kielty, Irene Shkolnikov, Ava Margolese, Jaime Arredondo Sanchez Lira, Chris Gill, Dennis Hore   +7 more
wiley   +1 more source

PSYCHEDELICS: CLINICAL EVIDENCE AND THERAPEUTIC MECHANISMS IN PSYCHIATRY [PDF]

Psychiatria Fennica
Interest and academic research on psychedelics and psychedelic-assisted therapy in the treatment of psychiatric disorders has increased dramatically in the past two decades. In many ways, psychedelics represent a new therapeutic paradigm in the context
JANI KAJANOJA, OSKARI KANTONEN, JUUSO KÄHÖNEN
doaj  

Factors associated with readmission to residential treatment among clients transitioned from detoxification services in Alberta, Canada

The American Journal on Addictions, Volume 35, Issue 5, Page 615-621, September 2026.
Abstract Background and Objectives Readmission to residential treatment increases healthcare costs, strains publicly funded systems, and may not adequately meet clients' needs. This study examined rates and predictors of readmission to residential treatment among clients transitioned from detoxification services.
Abreham Mekonnen
wiley   +1 more source